{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:13:55Z","timestamp":1788336835475,"version":"build-2803163510"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jdcr.2026.02.031","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:24:28Z","timestamp":1771547068000},"page":"76-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Near resolution of cutaneous lesions in long standing refractory dermatomyositis with deucravacitinib: A case report and literature review"],"prefix":"10.1016","volume":"71","author":[{"given":"Christopher","family":"Alihosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kopelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad P.","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jdcr.2026.02.031_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(25)00233-9","article-title":"Advances in the classification and management of idiopathic inflammatory myopathies","volume":"24","author":"Raaphorst","year":"2025","journal-title":"Lancet Neurol"},{"issue":"14","key":"10.1016\/j.jdcr.2026.02.031_bib2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa2117912","article-title":"Trial of intravenous immune globulin in dermatomyositis","volume":"387","author":"Aggarwal","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jdcr.2026.02.031_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf662","article-title":"Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study","volume":"65","author":"Retuerto-Guerrero","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jdcr.2026.02.031_bib4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000548207","article-title":"Successful treatment of refractory dermatomyositis with Deucravacitinib (Sotyktu): a case report","volume":"17","author":"Lapa","year":"2025","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.jdcr.2026.02.031_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jdcr.2025.01.047","article-title":"Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin","volume":"62","author":"McNamara","year":"2025","journal-title":"JAAD Case Rep"},{"issue":"12","key":"10.1016\/j.jdcr.2026.02.031_bib8","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archderm.1995.01690240040007","article-title":"Membrane attack complex deposits in cutaneous lesions of dermatomyositis","volume":"131","author":"Mascar\u00f3","year":"1995","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.02.031_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4331\/wjbc.v13.i1.1","article-title":"Current understanding of the role of tyrosine kinase 2 signaling in immune responses","volume":"13","author":"Muromoto","year":"2022","journal-title":"World J Biol Chem"},{"issue":"10","key":"10.1016\/j.jdcr.2026.02.031_bib10","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.42526","article-title":"The type I interferon signature reflects multiple phenotypic and activity measures in dermatomyositis","volume":"75","author":"Tabata","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.02.031_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"issue":"17","key":"10.1016\/j.jdcr.2026.02.031_bib12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s40265-022-01796-y","article-title":"Deucravacitinib: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jdcr.2026.02.031_bib7","first-page":"354","article-title":"Brepocitinib, a potent and selective TYK2\/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis","volume":"43","author":"Paik","year":"2025","journal-title":"Clin Exp Rheumatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626001116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626001116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:22:51Z","timestamp":1788333771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":11,"alternative-id":["S2352512626001116"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.02.031","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Near resolution of cutaneous lesions in long standing refractory dermatomyositis with deucravacitinib: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}